Cogitars GmbH was founded in 2013. The main focus of the company is on statistical support for Biotech- and Pharma Companies including Bayesian trials in phase 1, ranging from technical implementation to protocol writing and negotation with regulators. Cogitars has specific expertise in the field and, where required, works with a network of international experts to provide best solutions to its customers